Riskpilot← Back to searchSign inGet full accessPF Maxillofacial AB
ABActiveOrg 5568524176Töjnavägen 48 AMedical specialists activities · NACE 8622Est. 20110 employees
Revenue 2025
SEK 2,8M
-5% vs 2024
EBITDA margin
13.5%
-66% vs 2024
Equity ratio
53.7%
Financial strength
Net profit 2025
SEK 414K
-49% vs 2024
| Revenue | SEK 2,8M | -5% |
| EBITDA | SEK 377K | -66% |
| Net profit | SEK 414K | -49% |
| Total assets | SEK 1,9M | -7% |
| Equity | SEK 997K | +16% |
| Employees | 0 | — |
Legal name
PF Maxillofacial AB
Org number
5568524176
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
11 maj 2011
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva kirurgisk verksamhet framförallt inom oral och maxillofacial kirurgi inklusive rehabiliteringsvård, medicinsk konsultverksamhet som hälsoundersökning, rådgivning samt utbildning inom maxillofacial kirurgi samt därmed förenlig verksamhet.
Address
Töjnavägen 48 A
Email
payamfarzad@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 2 027 | 2 193 | 3 093 | 2 155 | 2 587 | 2 936 | 2 792 |
| Staff expenses | — | — | — | — | — | — | −1 368 | −1 395 | −681 | −916 |
| EBITDA | 281 | 215 | 190 | 262 | 571 | 518 | 18 | 314 | 1 097 | 377 |
| Depreciation & amort. | −12 | −12 | −24 | −24 | −24 | −24 | −7 | −7 | −7 | −7 |
| EBIT | 269 | 203 | 166 | 238 | 547 | 494 | 11 | 308 | 1 090 | 370 |
| Net financials | — | −1 | — | — | −1 | — | −1 | −2 | 13 | 28 |
| Profit before tax | 183 | 230 | 168 | 221 | 444 | 597 | 220 | 231 | 1 004 | 533 |
| Tax | −59 | −65 | −44 | −51 | −99 | −133 | −51 | −59 | −199 | −119 |
| Net profit | 124 | 165 | 124 | 170 | 345 | 464 | 169 | 172 | 805 | 414 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 855 | 791 | 779 | 1 038 | 1 348 | 2 023 | 1 509 | 1 316 | 1 990 | 1 857 |
| Equity | 258 | 263 | 222 | 227 | 396 | 860 | 629 | 416 | 861 | 997 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Short-term debt | 157 | 116 | 147 | 385 | 423 | 737 | 663 | 608 | 739 | 605 |
| Total debt | 157 | 116 | 147 | 385 | 423 | 737 | 663 | 609 | 739 | 605 |
EBITDA margin
13.5%
This company
15.8%
Market median
-15% vs market
20162025
Equity ratio
53.7%
This company
38.2%
Market median
+41% vs market
20162025
Return on equity
41.5%
This company
18.4%
Market median
+126% vs market
20162025
Net profit margin
14.8%
This company
8.1%
Market median
+83% vs market
20162025
Asset turnover
1.50×
This company
1.12×
Market median
+34% vs market
20162025
Debt / equity
0.86×
This company
0.62×
Market median
+39% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-05-01 – 2017-04-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-05-01 – 2016-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PF Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PF Maxillofacial AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Payam Farzad | Chief Executive Officer | 0 companies |
| Shabnam Zare Ganji | Deputy Board Member | 0 companies |